CNBC December 10, 2024
Annika Kim Constantino

Key Points

– Shares of Walgreens jumped about 20% on a report that the company is in talks to sell itself to private equity firm Sycamore Partners.

– Walgreens and Sycamore have been discussing a deal that could be completed early next year, The Wall Street Journal reported, citing people familiar with the matter.

– The report comes during a rough period for the retail pharmacy giant.

Shares of Walgreens jumped about 20% on Tuesday on a report that the company is in talks to sell itself to private equity firm Sycamore Partners.

Walgreens and Sycamore have been discussing a deal that could be completed early next year, The Wall Street Journal reported, citing people familiar with the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
What are pharmacy benefit managers? A health economist explains how lack of competition drives up drug prices

Share This Article